Missed cancer diagnoses during March to December 2020, modelled as the difference between the counterfactual cancer diagnoses had the COVID-19 pandemic not occurred, and the modelled diagnoses
| Type of cancer | No. (95% CI) of counterfactual cancer diagnoses | No. (95% CI) of modelled cancer diagnoses | No. (95% CI) of missed cancer diagnoses |
|---|---|---|---|
| Bladder | 712 (632 to 800) | 630 (585 to 673) | 82 (−15 to 187) |
| Breast | 2313 (2165 to 2462) | 1962 (1882 to 2040) | 350 (172 to 531) |
| Cervical | 116 (85 to 155) | 122 (103 to 141) | −6 (−45 to 40) |
| Colorectal | 1812 (1682 to 1949) | 1414 (1342 to 1485) | 398 (241 to 571) |
| Kidney | 458 (396 to 527) | 416 (381 to 451) | 42 (−32 to 122) |
| Lung | 1674 (1556 to 1803) | 1637 (1568 to 1708) | 37 (−110 to 194) |
| Melanoma | 800 (715 to 899) | 577 (537 to 619) | 223 (123 to 337) |
| Non-Hodgkin lymphoma | 695 (615 to 789) | 619 (577 to 663) | 76 (−20 to 185) |
| Prostate | 2277 (2136 to 2433) | 1794 (1719 to 1866) | 484 (316 to 671) |
| Uterine | 542 (473 to 619) | 520 (481 to 557) | 22 (−63 to 114) |
Note: CI = confidence interval.